Status and phase
Conditions
Treatments
About
This is a single-arm, open-label, dose-finding Phase I/II clinical trial to evaluate the safety, efficacy, cellular pharmacokinetics, and pharmacodynamics of CT1190B cells in patients with R/R LBCL.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
68 participants in 1 patient group
Loading...
Central trial contact
Lifeng Zhang Operations Director
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal